Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Core One Labs Inc. C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. The Company, through its wholly owned subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics.


CSE:COOL - Post by User

Comment by CancerSlayeron Jan 12, 2021 10:40pm
158 Views
Post# 32282547

RE:Great news today! The new business direct is looking great!

RE:Great news today! The new business direct is looking great!All is looking good Tony...

As you know, this thin strip technology has already been proven with cannabis.  The bigger potential lies in the fact that it can likely be applied to any drug/compound.  This form of sublingual/transmucosal delivery offers significantly more rapid onset of action (generally < 5-10 min. vs 1 to 2 hrs via oral route).   And if one needs longer duration of action, the sublingual dose can be repeated &/or even used with a delayed onset, longer-acting oral form of the drug.  The strip technology also allows for lower/safer dosing without the unwanted adverse effects.  Sublingual delivery should be a preferential route for many drugs, especially psychedelics & other psychoactive compounds.  There are also many who are adverse to taking pills or are unable to take them for various reasons.   I'm happy to see COOL pivot into a new/less competitive/better direction imo.  Business agility is no less important than execution.  Considering they have also expanded their powerhouse scientific team (including Dr. Hancock with all of his accolades & Dr. Sanderson, our former J&J research executive), this company shows a lot of promise moving forward.  Good luck...
<< Previous
Bullboard Posts
Next >>